From: Additional germline findings from a tumor profiling program
 | Accepted n = 1844 | Declined n = 103 | p-value †|
---|---|---|---|
Age– years (mean) | 57.6 | 57.6 | > 0.95 |
Gender - n | p-value ‡ | ||
 Female | 1235 (67%) | 71 (69%) | > 0.68 |
 Male | 609 (33%) | 32 (31%) | |
Race - n | |||
 White | 1003 (54%) | 56 (54%) | > 0.95 |
 Asian | 207 (11%) | 16 (16%) | |
 Black | 35 (2%) | 1 (1%) | |
 Mixed | 14 (1%) | 0 (0%) | |
 Unknown | 585 (32%) | 30 (29%) | |
Cancer site - n | |||
 Gynecological | 518 (28%) | 25 (24%) | 0.015 |
 Gastrointestinal | 382 (21%) | 19 (18%) | |
 Breast | 233 (13%) | 18 (17%) | |
 Lung | 227 (12%) | 17 (17%) | |
 Pancreas | 194 (11%) | 8 (8%) | |
 Sarcoma | 21 (1%) | 5 (5%) | |
 Others | 269 (15%) | 11(11%) | |
Prior genetic testing - n | |||
 Yes | 345 (19%) | 15 (15%) | 0.292 |
 No | 1499 (81%) | 88 (85%) | |
ECOG - n | |||
 0 | 760 (41%) | 37 (36%) | 0.288 |
 1 | 1084 (59%) | 66 (64%) |